<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The treatment of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0100309'>subdural hematoma</z:hpo> (CSDH) was developed through a wide range of methods and technique </plain></SENT>
<SENT sid="1" pm="."><plain>The excellent surgical treatment of CSDH is still controversial </plain></SENT>
<SENT sid="2" pm="."><plain>The authors report a case of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0100309'>subdural hematoma</z:hpo> in a patient with antibodies antiphospholipidis syndrome (S. of Hughes) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is characterized by arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (APL) </plain></SENT>
<SENT sid="4" pm="."><plain>APL are considered to be a cause of an acquired <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> leading to <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) </plain></SENT>
</text></document>